Improving the Performance and Reproducibility of Inverted Planar Perovskite Solar Cells Using Tetraethyl Orthosilicate as the Antisolvent
Source abstract
Abstract
-based planar PSC for engineering an efficient perovskite layer, achieving a power conversion efficiency of 17.02% on glass substrates and 14.49% on flexible polymer substrates with negligible hysteresis, which even outperformed TL and CB. More importantly, TEOS PSCs exhibited much higher reproducibility than that of their counterparts. These desirable features should be ascribed to the higher-quality perovskite films with larger grain size, reduced density of defects, and thus smoother carrier transportation and slower carrier recombination. This work drives another step toward industrial-scale commercialization of PSCs and also paves the way for environmentally friendly photovoltaic applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Perovskite Materials and Applications · Conducting polymers and applications · Quantum Dots Synthesis And Properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Optical and Electronic Information, Engineering Research Center for Functional Ceramics of the Ministry of Education, Huazhong University of Science and Technology, Wuhan 430074, P. R. China
Funding
Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China
References (38)
Show source-provided references
1. 10.1038/nature1234010.1038/nature12340 ↗
2. 10.1038/nature1250910.1038/nature12509 ↗
3. 10.1126/science.124398210.1126/science.1243982 ↗
4. 10.1038/s41560-018-0200-610.1038/s41560-018-0200-6 ↗
5. 10.1038/nature1413310.1038/nature14133 ↗
6. 10.1038/nchem.232410.1038/nchem.2324 ↗
7. 10.1039/C5EE03560K10.1039/C5EE03560K ↗
8. 10.1002/adma.20140246110.1002/adma.201402461 ↗
9. 10.1126/sciadv.150117010.1126/sciadv.1501170 ↗
10. 10.1039/c1nr10867k10.1039/c1nr10867k ↗
11. 10.1016/j.nanoen.2018.07.00510.1016/j.nanoen.2018.07.005 ↗
12. 10.1021/jacs.5b0493010.1021/jacs.5b04930 ↗
13. 10.1002/aenm.20170057610.1002/aenm.201700576 ↗
14. 10.1002/solr.20170021310.1002/solr.201700213 ↗
15. European Medicines Agency. ICH Guideline Q3C (R6) on Impurities: Guideline for Residual Solvents, EMA/CHMP/ICH/82260/2006, 2016; pp 1 35.
16. 10.1021/acs.chemmater.6b0535310.1021/acs.chemmater.6b05353 ↗
17. 10.1016/j.nanoen.2017.07.04610.1016/j.nanoen.2017.07.046 ↗
18. 10.1002/adma.20160392310.1002/adma.201603923 ↗
19. 10.1007/s40843-017-9027-110.1007/s40843-017-9027-1 ↗
20. 10.1039/C7TA06334B10.1039/C7TA06334B ↗
21. 10.1039/C6NR08741H10.1039/C6NR08741H ↗
22. 10.1021/acsami.6b1427010.1021/acsami.6b14270 ↗
23. 10.1002/adma.20150416810.1002/adma.201504168 ↗
24. 10.1039/C7SE00125H10.1039/C7SE00125H ↗
25. 10.1038/ncomms714210.1038/ncomms7142 ↗
26. 10.1016/j.nanoen.2017.02.01910.1016/j.nanoen.2017.02.019 ↗
27. 10.1039/C7SE00125H10.1039/C7SE00125H ↗
28. 10.1021/jacs.6b0632010.1021/jacs.6b06320 ↗
29. 10.1063/1.493972410.1063/1.4939724 ↗
30. 10.1021/acsenergylett.6b0021510.1021/acsenergylett.6b00215 ↗
31. 10.1039/c3cc49853k10.1039/c3cc49853k ↗
32. 10.1021/ar900134d10.1021/ar900134d ↗
33. 10.1039/C5EE02155C10.1039/C5EE02155C ↗
34. 10.1002/anie.20140038810.1002/anie.201400388 ↗
35. 10.1021/nn404323g10.1021/nn404323g ↗
36. 10.1021/nl404252e10.1021/nl404252e ↗
37. 10.1002/adma.20140539110.1002/adma.201405391 ↗
38. 10.1002/adma.20140539110.1002/adma.201405391 ↗